APA

Dodda B. R., Bondi C. D., Hasan M., Clafshenkel W. P., Gallagher K. M., Kotlarczyk M. P., Sethi S., Buszko E., Latimer J. J., Cline J. M., Witt-Enderby P. A. & Davis V. L. (2019). Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. : Frontiers in oncology.

Chicago

Dodda Balasunder R, Bondi Corry D, Hasan Mahmud, Clafshenkel William P, Gallagher Katie M, Kotlarczyk Mary P, Sethi Shalini, Buszko Ethan, Latimer Jean J, Cline J Mark, Witt-Enderby Paula A and Davis Vicki L. 2019. Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. : Frontiers in oncology.

Harvard

Dodda B. R., Bondi C. D., Hasan M., Clafshenkel W. P., Gallagher K. M., Kotlarczyk M. P., Sethi S., Buszko E., Latimer J. J., Cline J. M., Witt-Enderby P. A. and Davis V. L. (2019). Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. : Frontiers in oncology.

MLA

Dodda Balasunder R, Bondi Corry D, Hasan Mahmud, Clafshenkel William P, Gallagher Katie M, Kotlarczyk Mary P, Sethi Shalini, Buszko Ethan, Latimer Jean J, Cline J Mark, Witt-Enderby Paula A and Davis Vicki L. Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. : Frontiers in oncology. 2019.